Onyx Biotec (NSE:ONYX) Total Equity: ₹554.1 Mil (As of Mar. 2026)


NSE:ONYX Onyx Biotec Ltd NSE:ONYX
25 GF Score
Price ₹40.30
! 6 Warning Signs
View Full Analysis

What is Onyx Biotec Total Equity?

Onyx Biotec NSE:ONYX -2.66% 25 Total Equity is ₹554.1 Mil as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 25/100. The stock has 6 warning signs investors should review.

Onyx Biotec's total equity for the quarter that ended in Mar. 2026 was ₹554.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Onyx Biotec Total Equity Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec Total Equity Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
163.76 182.02 252.88 556.22 554.08

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial 252.88 0.00 556.22 547.22 554.08
NSE:ONYX
25GF Score
Onyx Biotec Ltd NSE:ONYX
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Onyx Biotec's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=951.546-397.468
=554.1

Onyx Biotec's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=951.546-397.468
=554.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹554.1 Mil mean?
Onyx Biotec (NSE:ONYX) has a Total Equity of ₹554.1 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Onyx Biotec and its competitors.
Is Onyx Biotec's Total Equity too high?
Onyx Biotec's current Total Equity is ₹554.1 Mil. Overall, Onyx Biotec has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Total Equity compare to ISRG and BDX?
Onyx Biotec's Total Equity of ₹554.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Onyx Biotec and its competitors. Onyx Biotec's current Total Equity is ₹554.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Total Equity of ₹554.1 Mil. The current Total Equity is ₹554.1 Mil. Onyx Biotec's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Total Equity is ₹554.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
25GF Score

Get the complete analysis for NSE:ONYX

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.30
Price